BI
WHWK

BVF Inc’s Whitehawk Therapeutics WHWK Stock Holding History

BVF Inc’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-318,205
Closed -$2.3M – 74
2023
Q1 		$2.3M Sell
318,205
-244,104
-43% -$2.61M 0.08% 64
2022
Q4 		$7.21M Sell
562,309
-316,776
-36% -$4.14M 0.3% 53
2022
Q3 		$12.4M Hold
879,085
– – 0.51% 50
2022
Q2 		$10.8M Hold
879,085
– – 0.52% 49
2022
Q1 		$14.9M Sell
879,085
-20,307
-2% -$389K 0.6% 45
2021
Q4 		$21.7M Sell
899,392
-247,660
-22% -$6.22M 0.79% 37
2021
Q3 		$33.7M Buy
+1,147,052
New +$35M 1.31% 20

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BVF Inc's WHWK Position: Q2 2023 in Review

BVF Inc sold out of Whitehawk Therapeutics (WHWK) in Q2 2023, closing a stake of 318,205 shares — an estimated $2.3M sold.

BVF Inc first reported a position in WHWK in Q3 2021 and held it in 7 quarters. The position peaked at $33.7M in Q3 2021. 67 funds tracked by Wall St. Rank hold WHWK as of Q2 2023.

  • BVF Inc reported no remaining Whitehawk Therapeutics position as of Q2 2023 after selling out during the quarter.
  • BVF Inc sold 318,205 Whitehawk Therapeutics shares in Q2 2023, an estimated $2.3M.
  • BVF Inc first reported a position in Whitehawk Therapeutics in Q3 2021 and held it in 7 quarters.
  • BVF Inc's Whitehawk Therapeutics position peaked at $33.7M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2023.

Based on BVF Inc's 13F filing for Q2 2023, filed 14 Aug 2023.